POLITICO Pro | Article | Experts fear FDA push to get neurological drugs to market faster shortchanges patients
The FDA’s accelerated approval process is under scrutiny, but the agency says it is key to bringing treatments to desperate patients faster.The FDA says accelerated approval is key to bringing treatments to desperate patients faster when no other options are available.Andrew Harnik/APThe push to bring new treatments sooner to patients with devastating neurological illnesses may be giving them…